MNQ 0.00% 0.0¢ minquest limited

Ann: ePAT selected for CSIRO's ON Accelerator Program-MNQ.AX, page-104

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 365 Posts.
    The ideal pain assessment tool would have the following attributes but when you consider these attributes and measure them against the tools available you realise that no one tool has all attributes:
    • Sensitive and free from bias;
    • Immediate information about accuracy and reliability;
    • Distinguishes between pain, unpleasantness and emotion;
    • Assesses experimental and clinical pain;
    • Absolute rather than relative scales;
    • Estimates confidence of predictions.
    CORRECTION..... ePAT does! We have come to the rescue!
    Last edited by ehealth: 30/04/16
 
watchlist Created with Sketch. Add MNQ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.